Compare Merck & Co., Inc. (MRK) vs Open Text Corporation (OTEX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Merck & Co., Inc. vs Open Text Corporation — how do they compare? Merck & Co., Inc. trades at $143.01 (market cap $351.28B), while Open Text Corporation trades at $23.36 (market cap $5.61B). The key difference: Merck & Co., Inc. is far larger — about 62.6× Open Text Corporation's market cap, and Open Text Corporation pays the higher dividend (4.82%). Which is the better fit depends on your goals — on Pluang, investors hold Merck & Co., Inc. for 98 Days and Open Text Corporation for 23 Days on average.
| MRK | OTEX | |
|---|---|---|
Market Cap | $351.28B | $5.61B |
Volume | 7,969,665 | 1,197,475 |
Sector | Health | Technology |
52-Week High | $156.43 | $39.69 |
52-Week Low | $82.49 | $20.01 |
Typical Hold Time | 98 Days | 23 Days |
Enterprise Value | $398.04B | $10.63B |
Dividend Yield | 2.39% | 4.82% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Merck (MRK) trades at $142.79, up 0.61% on the day, with a bearish technical signal despite beating earnings estimates in recent quarters. The company reported 2025 revenue of $65.01B and net income of $18.25B, with a high P/E ratio of 113.9 reflecting premium valuation. Recent news highlights Merck's acquisition of Terns Pharmaceuticals to bolster its oncology pipeline, while institutional investors have been increasing stakes.
The outlook is mixed: strong analyst consensus (68% buy ratings) and a $158.78 price target suggest upside, but high valuation and bearish technicals pose near-term risks. Key opportunities include pipeline expansion via M&A; risks involve integration challenges and patent pressures.
OpenText (OTEX) trades at $23.14, up 1.89% today, with strong technical momentum indicated by a bullish overall signal. The company demonstrates robust fundamentals with consistent earnings beats, posting Q2 2026 EPS of $1.23 versus $1.02 expected, and maintains healthy profitability with 12.26% net income margin. Recent corporate actions include a $1 billion senior secured notes offering and strategic AI partnerships, signaling growth initiatives.
The stock presents an attractive valuation opportunity with P/E of 9.01 and P/S of 1.1 below sector averages, supported by analyst consensus target of $28.30 implying 22% upside. Key risks include high debt levels at $6.34 billion and competitive pressures in the software sector. Institutional sentiment remains mixed with 42% buy ratings amid ongoing debt management efforts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Merck & Co., Inc.
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the firm's sales are generated in the United States.
Read more on MRK →About Open Text Corporation
Open Text Corporation is a global leader in Enterprise Information Management (EIM) software and solutions. The company provides a comprehensive platform that helps organizations manage, secure, and leverage their unstructured digital content, including documents, emails, and media files. OTEX's offerings span content management, business process management, customer experience management, and security, serving large enterprises across various industries worldwide.
Read more on OTEX →
